Ming Chao Hsu
Directeur/Membre du Conseil chez THEVAX GENETICS VACCINE CO LTD
Profil
Ming Chao Hsu is currently a Director at TheVax Genetics Vaccine Co., Ltd.
and a Professor at Taipei Medical University.
Previously, he worked as a Member-Supervisory Board at PharmaEngine, Inc. He holds a doctorate degree from The Ohio State University, a graduate degree from National Tsing-Hua University, and an undergraduate degree from Taipei Medical University.
Postes actifs de Ming Chao Hsu
| Sociétés | Poste | Début |
|---|---|---|
| THEVAX GENETICS VACCINE CO LTD | Directeur/Membre du Conseil | 26/06/2015 |
| Taipei Medical University | Corporate Officer/Principal | - |
Anciens postes connus de Ming Chao Hsu
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMAENGINE, INC. | Directeur/Membre du Conseil | - |
Formation de Ming Chao Hsu
| The Ohio State University | Doctorate Degree |
| Taipei Medical University | Undergraduate Degree |
| National Tsing-Hua University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARMAENGINE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
TheVax Genetics Vaccine Co., Ltd.
 TheVax Genetics Vaccine Co., Ltd. Pharmaceuticals: OtherHealth Technology TheVax Genetics Vaccine Co., Ltd. engages in the manufacture, research, and development of human vaccines. Its products include PEK fusion proteins such as TVGV-1 designed for the treatment of human papilloma virus (HPV). It also engages in the research of innovative health control solutions and provides biotechnology services. The company was founded by Hsiu Kang Chang on June 27, 2012 and is headquartered in Taipei, Taiwan. | Health Technology |
